According to the CDC:
“The safety profile of Fluzone High-Dose vaccine is similar to that of regular flu vaccines, although adverse events (which are also reported after regular flu vaccines) were reported more frequently after vaccination with Fluzone High-Dose.
The most common adverse events experienced during clinical studies were mild and temporary and included pain, redness and swelling at the injection site and headache, muscle aches, fever and malaise.”
The most common adverse events experienced during clinical studies were mild and temporary and included pain, redness and swelling at the injection site and headache, muscle aches, fever and malaise.”
However, if you read the package insert, it will clearly tell you that there is absolutely no evidence backing up this theory… It states:
“Data from clinical trials comparing Fluzone to Fluzone High-Dose among persons aged 65 years or older indicate that a stronger immune response (i.e. higher antibody levels) occurs after vaccination with Fluzone High-Dose.
Whether or not the improved immune response leads to greater protection against influenza disease after vaccination is not yet known. An ongoing study designed to determine the effectiveness of Fluzone High-Dose in preventing illness from influenza compared to Fluzone is expected to be completed in 2014-2015.”
Whether or not the improved immune response leads to greater protection against influenza disease after vaccination is not yet known. An ongoing study designed to determine the effectiveness of Fluzone High-Dose in preventing illness from influenza compared to Fluzone is expected to be completed in 2014-2015.”
What this means is that for the next four years or so, seniors receiving this much more potent dose of the flu vaccine are participating in what amounts to an uncontrolled experiment. There is already admission that nobody knows whether it will actually prevent seniors from getting the flu or not!
According to the package insert, the SAE’s reported during the post-approval use of the vaccine include:
Thrombocytopenia (abnormally low platelet count, which can result in abnormal bleeding)
Guillain-Barre syndrome (a serious disorder that occurs when the body's defense (immune) system mistakenly attacks part of the nervous system.)
Myelitis (spinal cord inflammation)
Facial palsy (Bell’s palsy)
Paresthesia (numbness/tingling of the skin)
Vasculitis (inflammatory destruction of blood vessels)
Stevens-Johnson syndrome ( a skin disorder due to an allergic reaction or infection. Symptoms: Fever; General ill feeling; Itching of the skin; Joint aches; Multiple skin lesions: Start quickly and may return; May spread)
Brachial neuritis (excruciating unilateral shoulder pain, followed by paralysis of shoulder)
Lymphadenopathy (enlarged lymph nodes)
Anaphylaxis (life-threatening whole-body allergic reaction)
Chest pain (angina)
Last year, Cochrane reviewed the available scientific evidence that flu shots protect the elderly, and the results were abysmal. The authors concluded that:“The available evidence is of poor quality and provides no guidance regarding the safety, efficacy or effectiveness of influenza vaccines for people aged 65 years or older.”
Cochrane Database of Systematic Reviews in 2006, found "no evidence that the flu vaccine is any more effective than a placebo in preventing influenza in children under two. The studies involved 260,000 children, age 6 to 23 months."
Two years, later, in 2008, another Cochrane review again concluded that “little evidence is available” that the flu vaccine is effective in preventing influenza in children under the age of two.
There is A Better Way - Watch This Video
No comments:
Post a Comment